IVBXF News and Press, Innovent Biologics Inc From 02/11/24

2024-02-11 01:25:00 ET Summary I-Mab Hangzhou will acquire rights to I-Mab’s drug assets in Greater China for $80 M. Anbogen Therapeutics raised $12.5M in a Series A funding round. to advance its two lead drug candidates. Bayer signed a non-binding Letter of Intent to m...

2023-12-31 01:55:00 ET Summary Elpiscience Biopharma forms a $1.7 billion collaboration with Astellas Pharma to develop a bispecific macrophage engager. AstraZeneca acquires Gracell Biotech in a deal worth up to $1.2 billion, including a clinical stage CAR-T therapy. Jinan Qil...

2023-12-28 04:13:45 ET More on Innovent Biologics: Innovent marks China's first regulatory review of a KRAS G12C inhibitor Historical earnings data for Innovent Biologics Financial information for Innovent Biologics For further details see: Innovent Biolo...

2023-12-10 02:15:00 ET Summary Shanghai Abbisko Therapeutics has sold greater China commercialization rights for pimicotinib to Germany's Merck in a $605 million deal. Xtalpi, a China-US AI drug discovery company, has filed for a Hong Kong IPO after raising $780 million in venture...

2023-12-03 04:30:00 ET Summary LianBio, a Princeton-Shanghai in-licensing company, received a $465 million buyout offer from Tang Capital Management. Perpetual Medicines, a Shanghai-Boston AI startup, closed an $8 million seed financing to advance its peptide drug discovery platfo...

2023-11-24 06:48:01 ET More on Innovent Biologics Historical earnings data for Innovent Biologics Financial information for Innovent Biologics Historical earnings data for Innovent Biologics, Inc. Financial information for Innovent Biologics, Inc. For...

2023-06-18 07:05:00 ET Summary San Diego-Shanghai company Cullgen will collaborate with Japan's Astellas Pharma to discover multiple innovative protein degraders in a deal worth up to $1.9 billion. Cholesgen (Shanghai) formed a three-year collaboration with AstraZeneca to develop ...

2023-06-03 12:00:00 ET The American Society of Clinical Oncology ( OTC:ASCO ) annual meeting just got underway Friday in Chicago, kicking off the cancer community's largest medical meeting of the year. The event is closely watched by many investors as companies large and small m...

2023-05-14 14:20:00 ET Summary Bliss Biopharma (Hangzhou) announced it may out-license global rights (ex-China) for its HER2 ADC to Japan’s Eisai Pharma in a deal with a potential value of $2 billion. Shanghai Junshi Bio out-licensed regional rights for its anti-PD-1 mAb to...

2023-04-17 09:00:14 ET Summary Sana Biotechnology has two recent pre-clinical studies that showed positive results. SANA shares were up >50% for the week, but prices are likely to slide down in the near-term. Sana Biotechnology doesn't know how to promote or position its pi...